ROCHESTER, Minn. — Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney trans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results